Ellen Jovita Tjitradi, Harapan Parlindungan Ringoringo, Roselina Panghiyangani, Edi Hartoyo, Rahmiati Rahmiati
{"title":"Profil Hematologi pada Bayi Baru Lahir dari Ibu Suspek Covid-19 di RSD Idaman Banjarbaru Tahun 2020-2021","authors":"Ellen Jovita Tjitradi, Harapan Parlindungan Ringoringo, Roselina Panghiyangani, Edi Hartoyo, Rahmiati Rahmiati","doi":"10.20527/ht.v5i2.6275","DOIUrl":null,"url":null,"abstract":"Abstract: Coronavirus Disease 2019 (COVID-19) is a disease caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and it is highly contagious. This study aims to determine the hematological profile which includes erythrocytes (RBC), RDW, Hb, hematocrit, MCV, MCH, MCHC, leukocytes (leukocyte differential Count: basophils, eosinophils, neutrophils, lymphocytes, monocytes), platelets, and NLR in newborns from mothers with suspected COVID-19 at the Idaman Hospital Banjarbaru 2020-2021. This research method is descriptive retrospective with data collection through patient medical records. The sampling technique is purposive sampling. In this study, a total sample of 83 neonates from pregnant women with suspected COVID-19 was obtained. However, from the 83 sample, the sample that has hematological profile data and meets the criteria is 69 sample. The results showed that 42 neonates (62,69%) with reactive IgM tests, and 51 neonates (76,12%) with nonreactive IgG tests. In the distribution of the hematological profile of newborns from mothers with suspected COVID-19, found an increase NLR in 33 neonates (47,83%), an increase hemoglobin in 8 neonates (11,59%), an increase hematocrit in 10 neonates (14,49%), an increase MCV in 8 neonates (11,59%), and decrease MCHC in 8 neonates (11,59%). Keywords: hematology profile, newborns, suspected COVID-19 Abstrak: Coronavirus Disease 2019 (COVID-19) adalah penyakit yang disebabkan oleh virus Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) dan sangat menular. Penelitian ini bertujuan untuk mengetahui profil hematologi yang meliputi eritrosit (RBC), RDW, Hb, hematokrit, MCV, MCH, MCHC, leukosit (hitung jenis : basofil, eosinofil, neutrofil, limfosit, monosit), trombosit, dan NLR pada bayi baru lahir dari ibu suspek COVID-19 di RSD Idaman Banjarbaru Tahun 2020-2021. Metode penelitian ini adalah deskriptif retrospektif dengan pengambilan data melalui rekam medis pasien. Teknik pengambilan sampel adalah purposive sampling. Dalam penelitian ini didapatkan total sampel 83 neonatus dari ibu hamil dengan suspek COVID-19. Namun, dari 83 sampel tersebut, sampel yang memiliki data profil hematologi dan memenuhi kriteria berjumlah 69 sampel. Hasil penelitian menunjukkan pada pemeriksaan rapid test IgM neonatus ditemukan hasil reaktif sebanyak 42 neonatus (62,69%) dan rapid test IgG ditemukan hasil non reaktif sebanyak 51 neonatus (76,12%). Distribusi profil hematologi bayi baru lahir dari ibu suspek COVID-19 ditemukan peningkatan NLR sebanyak 33 neonatus (47,83%), peningkatan hemoglobin sebanyak 8 neonatus (11,59%), peningkatan hematokrit sebanyak 10 neonatus (14,49%), peningkatan MCV sebanyak 8 neonatus (11,59%), dan penurunan MCHC sebanyak 8 neonatus (11,59%). Kata-kata kunci: profil hematologi, bayi baru lahir, suspek COVID-19","PeriodicalId":77544,"journal":{"name":"Homeostasis in health and disease : international journal devoted to integrative brain functions and homeostatic systems","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Homeostasis in health and disease : international journal devoted to integrative brain functions and homeostatic systems","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20527/ht.v5i2.6275","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Abstract: Coronavirus Disease 2019 (COVID-19) is a disease caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and it is highly contagious. This study aims to determine the hematological profile which includes erythrocytes (RBC), RDW, Hb, hematocrit, MCV, MCH, MCHC, leukocytes (leukocyte differential Count: basophils, eosinophils, neutrophils, lymphocytes, monocytes), platelets, and NLR in newborns from mothers with suspected COVID-19 at the Idaman Hospital Banjarbaru 2020-2021. This research method is descriptive retrospective with data collection through patient medical records. The sampling technique is purposive sampling. In this study, a total sample of 83 neonates from pregnant women with suspected COVID-19 was obtained. However, from the 83 sample, the sample that has hematological profile data and meets the criteria is 69 sample. The results showed that 42 neonates (62,69%) with reactive IgM tests, and 51 neonates (76,12%) with nonreactive IgG tests. In the distribution of the hematological profile of newborns from mothers with suspected COVID-19, found an increase NLR in 33 neonates (47,83%), an increase hemoglobin in 8 neonates (11,59%), an increase hematocrit in 10 neonates (14,49%), an increase MCV in 8 neonates (11,59%), and decrease MCHC in 8 neonates (11,59%). Keywords: hematology profile, newborns, suspected COVID-19 Abstrak: Coronavirus Disease 2019 (COVID-19) adalah penyakit yang disebabkan oleh virus Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) dan sangat menular. Penelitian ini bertujuan untuk mengetahui profil hematologi yang meliputi eritrosit (RBC), RDW, Hb, hematokrit, MCV, MCH, MCHC, leukosit (hitung jenis : basofil, eosinofil, neutrofil, limfosit, monosit), trombosit, dan NLR pada bayi baru lahir dari ibu suspek COVID-19 di RSD Idaman Banjarbaru Tahun 2020-2021. Metode penelitian ini adalah deskriptif retrospektif dengan pengambilan data melalui rekam medis pasien. Teknik pengambilan sampel adalah purposive sampling. Dalam penelitian ini didapatkan total sampel 83 neonatus dari ibu hamil dengan suspek COVID-19. Namun, dari 83 sampel tersebut, sampel yang memiliki data profil hematologi dan memenuhi kriteria berjumlah 69 sampel. Hasil penelitian menunjukkan pada pemeriksaan rapid test IgM neonatus ditemukan hasil reaktif sebanyak 42 neonatus (62,69%) dan rapid test IgG ditemukan hasil non reaktif sebanyak 51 neonatus (76,12%). Distribusi profil hematologi bayi baru lahir dari ibu suspek COVID-19 ditemukan peningkatan NLR sebanyak 33 neonatus (47,83%), peningkatan hemoglobin sebanyak 8 neonatus (11,59%), peningkatan hematokrit sebanyak 10 neonatus (14,49%), peningkatan MCV sebanyak 8 neonatus (11,59%), dan penurunan MCHC sebanyak 8 neonatus (11,59%). Kata-kata kunci: profil hematologi, bayi baru lahir, suspek COVID-19
摘要:冠状病毒病2019 (COVID-19)是一种由严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)引起的疾病,具有高度传染性。本研究旨在确定2020-2021年班贾巴鲁伊达曼医院疑似COVID-19母亲所生新生儿的血液学特征,包括红细胞(RBC)、RDW、Hb、红细胞压积、MCV、MCH、MCHC、白细胞(白细胞差异计数:嗜碱性粒细胞、嗜酸性粒细胞、中性粒细胞、淋巴细胞、单核细胞)、血小板和NLR。本研究方法为描述性回顾性研究,通过患者病历收集资料。抽样技术是有目的的抽样。本研究共采集疑似COVID-19孕妇的83例新生儿样本。然而,从83个样本中,有血液学资料且符合标准的样本是69个样本。结果显示,42例(62.69%)新生儿IgM检测有反应,51例(76.12%)新生儿IgG检测无反应。在疑似COVID-19母亲的新生儿血液学分布中,发现33例新生儿NLR升高(47.83%),8例新生儿血红蛋白升高(11.59%),10例新生儿红细胞压积升高(14.49%),8例新生儿MCV升高(11.59%),8例新生儿MCHC降低(11.59%)。摘要:冠状病毒病2019 (COVID-19) adalah penyakit yang disebabkan oleh病毒严重急性呼吸综合征冠状病毒2 (SARS-CoV-2) dan sangat menular。杨Penelitian ini bertujuan为她mengetahui资料hematologi meliputi eritrosit (RBC), RDW, Hb, hematokrit、MCV、妇幼保健、MCHC, leukosit (hitung jenis: basofil, eosinofil, neutrofil, limfosit, monosit), trombosit,丹NLR篇八一巴鲁lahir达里语的伊布·suspek COVID-19 di RSD Idaman Banjarbaru Tahun 2020 - 2021。对数据数据进行了分析,并对数据数据进行了分析。技术样本,即目的性抽样。Dalam penelitian ini didapatkan总样本为83名新生儿,其中包括疑似COVID-19的新生儿。Namun,达83个样本,样本阳记忆数据概况血液学和记忆标准berjumlah 69个样本。快速检测IgM新生儿ditemukan Hasil reaktif sebanyak 42(62,69%),快速检测IgG ditemukan Hasil non - reaktif sebanyak 51(76,12%)。血清学分布、血清学特征、血清学分布、血清学分布、血清学分布、血清学分布、血清学分布、血清学分布、血清学分布、血清学分布、血清学分布、血清学分布、血清学分布、血清学分布、血清学分布、血清学分布、血清学分布、血清学分布、血清学分布等。Kata-kata kunci:血液学特征,八一baru - lahir,疑似COVID-19